MAYWOOD, IL - A new generation of blood thinners can reduce the risk of stroke in patients with atrial fibrillation, without requiring frequent monitoring and dietary restrictions.
But special attention must be given to the patient's age, kidney function and other factors before prescribing the new medications, according to an article by neurologists at Loyola Medicine and Loyola University Chicago Stritch School of Medicine.
The report by Rochelle Sweis, DO and José Biller, MD, is published in the journal Current Treatment Options in Cardiovascular Medicine.